Winters T A, Weinfeld M, Jorgensen T J
Department of Radiation Medicine, Vincent T. Lombardi Cancer Research Center, Georgetown University Medical Center, Washington DC 20007.
Nucleic Acids Res. 1992 May 25;20(10):2573-80. doi: 10.1093/nar/20.10.2573.
We have purified three chromatographically distinct human enzyme activities from HeLa cells, that are capable of converting bleomycin-treated DNA into a substrate for E. coli DNA polymerase I. The bleomycin-treated DNA substrate used in this study has been characterized via a 32P-postlabeling assay and shown to contain strand breaks with 3'-phosphoglycolate termini as greater than 95% of the detectable dose-dependent lesions. The purified HeLa cell enzymes were shown to be capable of removing 3'-phosphoglycolates from this substrate. Also 3'-phosphoglycolate removal and nucleotide incorporation were enzyme dependent. In addition, all three Hela cell enzymes have been determined to possess Class II AP endonuclease activity. The enzymes lack 3'----5' exonuclease activity and are, therefore, dissimilar to exonuclease III--an E. coli enzyme that can remove 3'-phosphoglycolate.
我们从HeLa细胞中纯化出了三种色谱性质不同的人类酶活性物质,它们能够将经博来霉素处理的DNA转化为大肠杆菌DNA聚合酶I的底物。本研究中使用的经博来霉素处理的DNA底物已通过32P后标记分析法进行了表征,结果显示,超过95%的可检测剂量依赖性损伤含有3'-磷酸乙醇酸末端的链断裂。纯化后的HeLa细胞酶能够从该底物中去除3'-磷酸乙醇酸。此外,3'-磷酸乙醇酸的去除和核苷酸掺入均依赖于酶。另外,已确定所有三种HeLa细胞酶均具有II类AP核酸内切酶活性。这些酶缺乏3'→5'外切核酸酶活性,因此与能够去除3'-磷酸乙醇酸的大肠杆菌核酸外切酶III不同。